Biomedical Engineering Reference
In-Depth Information
[513] Mantripragada S. A lipid based depot (DepoFoam technology) for sustained release
drug delivery. Prog Lipid Res 2002;41:392-406.
[514] Angst MS, Drover DR. Pharmacology of drugs formulated with DepoFoam: a sustained
release drug delivery system for parenteral administration using multivesicular lipo-
some technology. Clin Pharmacokinet 2006;45:1153-76.
[515] Sankaram MB, Kim S. Multivesicular liposomes with controlled release of encapsu-
lated biologically active substances. US Patent 5, 766, 627. 1998.
[516] Kim S, Howell SB. Multivesicular liposomes having a biologically active substance
encapsulated therein in the presence of a hydrochloride. US Patent 5, 807, 572. 1998.
[517] Willis RC. Method for utilizing neutral lipids to modify in-vivo release from multive-
sicular liposomes. US Patent 5, 891, 467. 1998.
[518] Haijun Z, Yingjie D, Xiumin W, Binghua Y. Multivesicular liposome formulation for the
sustained delivery of breviscapine. Int J Pharm 2005;301:15-24.
[519] Qiang Y, John A, Mark S, Elizabeth B, Nandini VK. DepoFoam technology: a vehicle
for controlled delivery of protein and peptide drugs. J Control Release 2000;64:155-66.
[520] Jian Q, Xiao W, Fang G, Rui L, Jing-wu Z, Yu-hong X. Multivesicular liposome formu-
lations for the sustained delivery of interferon -2b. New Acta Pharmacol Sin 2005;26:
1395-401.
[521] Katre NV, Asherman J, Schaefer H, Hora M. Multivesicular liposome (DepoFoam)
technology for the sustained delivery of insulin-like growth factor-1 (IGF-1). J Pharm
Sci 1997;87:1341-6.
[522] Ramprasad MP, Anantharamaiah GM, Garber DW, Katre NV. Sustained-delivery of an
apolipoprotein E peptidomimetic using multivesicular liposomes lowers serum choles-
terol levels. J Control Release 2002;79:207-18.
[523] Chamberlain MC, Khatibi S, Kim JC, Howell SB, Chatelut E, Kim S. Treatment of
leptomeningeal metastasis with intraventricular administration of Depot Cytarabine
(DTC101). Arch Neurol 1993;50:261-64.
[524] Langston MV, Ramprasad MP, Kararli TT, Galluppi GR, Katre NV. Modulation of the
sustained delivery of myelopoietin (Leridistim) encapsulated in multivesicular lipo-
somes (DepoFoam). J Control Release 2003;89:87-99.
[525] Van SM, Visser A, Van HA, Storm G, Crommelin D, Jiskoot W. Conformational stabil-
ity of human interferon-gamma on association with and dissociation from liposomes.
J Pharm Sci 2000;89:1605-19.
[526] Ramprasad MP, Amini A, Kararli T, Katre NV. The sustained granulopoietic effect of
progenipoietin encapsulated in multivesicular liposomes. Int J Pharm 2003;261:93-103.
[527] Howell SB. Clinical application of a novel sustained-release injectable drug delivery
system: DepoFoam™ Technology. Cancer J 2001;7:219-27.
Search WWH ::
Custom Search